What Is Neupro? Uses, Dosage, and What You Need to Know in 2026

Neupro is a prescription medication in the form of a transdermal patch that delivers the drug rotigotine through your skin, directly into your bloodstream. It is used to treat Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome (RLS). Neupro was first approved by the FDA in 2007 and is manufactured by UCB, Inc. As of 2026, it remains the only FDA-approved dopamine agonist available as a transdermal patch in the United States.

What Conditions Does Neupro Treat?

Neupro is FDA-approved for two conditions:

1. Parkinson's Disease (PD): Neupro is approved for both early-stage Parkinson's (as the first medication, before levodopa) and advanced-stage Parkinson's (in combination with levodopa, to reduce 'off' time when levodopa wears off). It helps manage PD symptoms including tremors, stiffness, slowness of movement, and problems with balance.
2. Moderate-to-Severe Primary Restless Legs Syndrome (RLS): RLS causes uncomfortable sensations in the legs (crawling, itching, throbbing) and an irresistible urge to move them, particularly at rest and at night. Neupro is approved for moderate-to-severe primary RLS — meaning RLS not caused by another underlying medical condition.

How Is Neupro Different from Other Parkinson's Medications?

Neupro stands out from other Parkinson's medications in two important ways: its delivery method and its pharmacological profile.

• Delivery method: Unlike oral medications that must be swallowed and processed by the digestive system, Neupro delivers medication continuously through the skin for 24 hours. This creates steady drug levels in the blood without the peaks and troughs of oral dosing, which is beneficial for Parkinson's patients who experience 'wearing off' symptoms between doses.
• Pharmacological profile: Rotigotine is a non-ergoline dopamine agonist that stimulates D3, D2, and D1 receptors — a broader receptor profile than pramipexole (D2/D3 focused). This may provide additional benefits though the clinical significance of the D1 activation is still studied.

What Dosage Strengths Does Neupro Come In?

Neupro is available in six strengths, each releasing a different amount of rotigotine over 24 hours:

• 1 mg/24h — used for RLS starting dose
• 2 mg/24h — starting dose for early-stage PD
• 3 mg/24h — maximum dose for RLS
• 4 mg/24h — starting dose for advanced-stage PD; common maintenance dose for early PD
• 6 mg/24h — maximum dose for early-stage PD
• 8 mg/24h — maximum dose for advanced-stage PD

How Do You Use the Neupro Patch?

Using the Neupro patch correctly is important for the medication to work effectively. Follow these steps:

1. Choose your application site: You can apply Neupro to the front of your abdomen (stomach), thigh, hip, side of your body (flank), shoulder, or upper arm.
2. Prepare the skin: The skin must be clean, dry, and intact. Do not apply to oily, irritated, or damaged skin. Do not apply where clothing rubs tightly.
3. Apply the patch: Peel off the protective liner, place the patch on your skin, and press firmly for 30 seconds to ensure good adhesion.
4. Leave on for 24 hours: Apply a new patch at the same time each day. Remove the old patch before applying the new one.
5. Rotate sites: Do not apply to the same area of skin more than once every 14 days. Rotating sites prevents skin irritation.

Can I Shower, Bathe, or Swim With the Neupro Patch?

Yes — you can shower, bathe, or swim while wearing a Neupro patch. Getting the patch wet is not harmful, but vigorous rubbing of the site may loosen the patch. If the patch comes off during bathing, apply a new one to a different site and continue with your regular schedule the next day.

Key Safety Points for Neupro

• Do NOT stop Neupro suddenly — taper under your doctor's supervision to avoid withdrawal symptoms
• Remove the patch before MRI or cardioversion — the aluminum backing causes skin burns in these procedures
• Avoid heat on the patch (heating pads, saunas, sunlight) — heat increases drug absorption and can cause an overdose effect
• Do not cut the patch — this changes the drug release mechanism
• Neupro is NOT a controlled substance — any licensed prescriber can write a prescription

The Bottom Line

Neupro (rotigotine) is the only transdermal dopamine agonist patch approved in the US for Parkinson's disease and RLS. Its 24-hour continuous delivery is a real clinical advantage for patients who struggle with oral dosing consistency. If you have a prescription and need help finding it in stock, medfinder can locate pharmacies near you that have it. For a deeper explanation of how it works, see our guide on how Neupro works.